Adaptive Biotechnologies (ADPT) Other Non-Current Assets (2018 - 2025)
Historic Other Non-Current Assets for Adaptive Biotechnologies (ADPT) over the last 8 years, with Q3 2025 value amounting to $2.7 million.
- Adaptive Biotechnologies' Other Non-Current Assets fell 1000.0% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year decrease of 1000.0%. This contributed to the annual value of $2.9 million for FY2024, which is 1924.26% down from last year.
- Latest data reveals that Adaptive Biotechnologies reported Other Non-Current Assets of $2.7 million as of Q3 2025, which was down 1000.0% from $2.7 million recorded in Q2 2025.
- In the past 5 years, Adaptive Biotechnologies' Other Non-Current Assets registered a high of $3.6 million during Q4 2023, and its lowest value of $2.1 million during Q1 2021.
- In the last 5 years, Adaptive Biotechnologies' Other Non-Current Assets had a median value of $2.7 million in 2025 and averaged $2.7 million.
- Its Other Non-Current Assets has fluctuated over the past 5 years, first surged by 4962.5% in 2023, then plummeted by 2002.95% in 2025.
- Quarter analysis of 5 years shows Adaptive Biotechnologies' Other Non-Current Assets stood at $2.1 million in 2021, then grew by 12.25% to $2.4 million in 2022, then skyrocketed by 49.62% to $3.6 million in 2023, then decreased by 19.24% to $2.9 million in 2024, then dropped by 6.9% to $2.7 million in 2025.
- Its Other Non-Current Assets stands at $2.7 million for Q3 2025, versus $2.7 million for Q2 2025 and $2.7 million for Q1 2025.